Lung adenocarcinoma harbours numerous molecular abnormalities, including mutation of the epidermal growth factor (EGF), rearrangement of the gene for anaplastic lymphoma kinase (ALK), and mutations for Kirsten rat sarcoma viral oncogene homologue (KRAS). This evidence concerns the gene EGF and lung adenocarcinoma.